Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus

被引:9
作者
El Eter, E. [1 ,2 ,3 ]
Al-Masri, A. A. [1 ,2 ]
机构
[1] King Saud Univ, Fac Med, Dept Physiol, Riyadh, Saudi Arabia
[2] King Saud Univ, Fac Med, Cardiovasc Res Grp, Riyadh, Saudi Arabia
[3] Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt
关键词
Peroxiredoxins; Type 2 diabetes mellitus; Oxidative stress; Cardiovascular risk factors; BLOOD-PRESSURE CONTROL; C-REACTIVE PROTEIN; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; DISEASE; ATHEROSCLEROSIS; SECRETION;
D O I
10.1590/1414-431X20144142
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The production of oxygen free radicals in type 2 diabetes mellitus contributes to the development of complications, especially the cardiovascular-related ones. Peroxiredoxins (PRDXs) are antioxidant enzymes that combat oxidative stress. The aim of this study was to investigate the associations between the levels of PRDX isoforms (1, 2, 4, and 6) and cardiovascular risk factors in type 2 diabetes mellitus. Fifty-three patients with type 2 diabetes mellitus (28F/25M) and 25 healthy control subjects (7F/18M) were enrolled. We measured the plasma levels of each PRDX isoform and analyzed their correlations with cardiovascular risk factors. The plasma PRDX1, -2, -4, and -6 levels were higher in the diabetic patients than in the healthy control subjects. PRDX2 and -6 levels were negatively correlated with diastolic blood pressure, fasting blood sugar, and hemoglobin A1c. In contrast, PRDX1 levels were positively correlated with low-density lipoprotein and C-reactive protein levels. PRDX4 levels were negatively correlated with triglycerides. In conclusion, PRDX1, -2, -4, and -6 showed differential correlations with a variety of traditional cardiovascular risk factors. These results should encourage further research into the crosstalk between PRDX isoforms and cardiovascular risk factors.
引用
收藏
页码:465 / 469
页数:5
相关论文
共 27 条
[1]   Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All-Cause Mortality [J].
Abbasi, Ali ;
Corpeleijn, Eva ;
Postmus, Douwe ;
Gansevoort, Ron T. ;
de Jong, Paul E. ;
Gans, Rijk O. B. ;
Struck, Joachim ;
Schulte, Janin ;
Hillege, Hans L. ;
van der Harst, Pim ;
Peelen, Linda M. ;
Beulens, Joline W. J. ;
Stolk, Ronald P. ;
Navis, Gerjan ;
Bakker, Stephan J. L. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (05) :e002956
[2]  
Al-Masri AA, 2014, EUR REV MED PHARMACO, V18, P710
[3]   Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial [J].
Anderson, Robert J. ;
Bahn, Gideon D. ;
Moritz, Thomas E. ;
Kaufman, Derrick ;
Abraira, Carlos ;
Duckworth, William .
DIABETES CARE, 2011, 34 (01) :34-38
[4]   Targeting Redox Signaling in the Vascular Wall: From Basic Science to Clinical Practice [J].
Antoniades, Charalambos ;
Antonopoulos, Alexios S. ;
Bendall, Jennifer K. ;
Channon, Keith M. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (03) :329-342
[5]   Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy [J].
Bhatia, S ;
Shukla, R ;
Madhu, SV ;
Gambhir, JK ;
Prabhu, KM .
CLINICAL BIOCHEMISTRY, 2003, 36 (07) :557-562
[6]   Influence of Glycemic Status and Physical Fitness on Oxidative Stress and the Peroxiredoxin System in the Erythrocytes of Non-Insulin-Dependent Type 2 Diabetic Men [J].
Brinkmann, C. ;
Neumann, E. ;
Blossfeld, J. ;
Frese, S. ;
Orthmann, P. ;
Montiel, G. ;
Bloch, W. ;
Brixius, K. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (09) :559-564
[7]   Transforming growth factor-β1 induces the non-classical secretion of peroxiredoxin-I in A549 cells [J].
Chang, Jong Wook ;
Lee, Seung Hee ;
Lu, Yan ;
Yoo, Yung Joon .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (01) :118-123
[8]   Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease [J].
El Eter, Eman ;
Al Masri, Abeer ;
Habib, Shahid ;
Al Zamil, Hana ;
Al Hersi, Ahmed ;
Al Hussein, Fawaz ;
Al Omran, Mohamed .
CELL STRESS & CHAPERONES, 2014, 19 (02) :173-181
[9]  
Estacio RO, 2000, DIABETES CARE, V23, pB54
[10]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47